Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:58:20.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical study involving Nivolumab for biliary tract cancer, while adding references to the study's collaborators and a new version revision.
    Difference
    41%
    Check dated 2025-04-16T02:20:01.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.4%
    Check dated 2025-04-09T00:39:28.000Z thumbnail image
  5. Check
    29 days ago
    No Change Detected
  6. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:17:49.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The webpage has updated its date references, moving from late 2024 to early 2025, indicating a shift in the timeline of the content. The phrase 'Last Update Posted' has also been modified to include an estimated date.
    Difference
    0.8%
    Check dated 2025-02-17T13:32:21.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.
    Difference
    1%
    Check dated 2025-02-10T09:24:49.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.